HEADER TRANSCRIPTION 10-JUN-10 2KZ0 TITLE SOLUTION STRUCTURE OF A BOLA PROTEIN (ECH_0303) FROM EHRLICHIA TITLE 2 CHAFFEENSIS. SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS TITLE 3 DISEASE TARGET EHCHA.10365.A COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOLA FAMILY PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: EHRLICHIA CHAFFEENSIS; SOURCE 3 ORGANISM_TAXID: 205920; SOURCE 4 STRAIN: ARKANSAS; SOURCE 5 GENE: ECH_0303; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: AVA0421 KEYWDS BOLA PROTEIN FAMILY, HUMAN MONOCYTOTROPIC EHRLICHIOSIS, STRESS KEYWDS 2 RESPONSE, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER KEYWDS 3 FOR INFECTIOUS DISEASE, SSGCID, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.W.BUCHKO,SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE AUTHOR 2 (SSGCID) REVDAT 3 22-MAY-24 2KZ0 1 REMARK REVDAT 2 16-MAR-22 2KZ0 1 REMARK SEQADV REVDAT 1 23-JUN-10 2KZ0 0 JRNL AUTH G.W.BUCHKO,S.N.HEWITT,A.J.NAPULI,W.C.VAN VOORHIS,P.J.MYLER JRNL TITL STRUCTURAL CHARACTERIZATION OF A BOLA PROTEIN (ECH_0303) JRNL TITL 2 FROM EHRLICHIA CHAFFEENSIS, THE AGENT RESPONSIBLE FOR HUMAN JRNL TITL 3 MONOCYTOTROPIC EHRLICHIOSIS. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1, CNS 1.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION WAS PERFORMED REMARK 3 ITERATIVELY USING CYANA (AUTOMATED NOESY ASSIGNMENTS). A TOTAL REMARK 3 OF 20 STRUCTURES OUT OF 100 WITH LOWEST TARGET FUNCTION FROM THE REMARK 3 FINAL CYANA CALCULATION WERE TAKEN AND REFINED BY RESTRAINED REMARK 3 MOLECULAR DYNAMICS/ENERGY MINIMIZATION IN EXPLICIT WATER (CNS) REMARK 3 AFTER ADDING 1% TO THE UPPER BOUNDARY LIMIT OF THE DISTANCE REMARK 3 RESTRAINTS. REMARK 4 REMARK 4 2KZ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000101750. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.1 REMARK 210 IONIC STRENGTH : 0.12 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.5 MM [U-99% 13C; U-99% 15N] REMARK 210 ECH_0303, 100 MM SODIUM CHLORIDE, REMARK 210 20 MM TRIS, 1 MM DTT, 90% H2O/ REMARK 210 10% D2O; 1.0 MM [U-99% 13C; U-99% REMARK 210 15N] ECH_0303, 100 MM SODIUM REMARK 210 CHLORIDE, 20 MM TRIS, 1 MM DTT, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCACB; 3D HNCO; 3D HN(COCA) REMARK 210 CB; 3D HCCH-TOCSY; 3D 1H-15N REMARK 210 NOESY; 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX 2007, SPARKY 3.115 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 33 -43.75 -145.55 REMARK 500 2 GLU A 21 30.49 -99.63 REMARK 500 2 HIS A 67 -54.26 -166.92 REMARK 500 3 ASP A 32 90.15 61.57 REMARK 500 3 ASP A 62 -47.56 75.38 REMARK 500 4 ASN A 33 36.01 -96.00 REMARK 500 4 GLN A 70 28.69 -145.78 REMARK 500 5 ASP A 32 -67.15 -100.73 REMARK 500 5 ASP A 62 76.65 58.50 REMARK 500 5 LEU A 64 -80.41 -110.50 REMARK 500 6 LEU A 64 71.63 63.44 REMARK 500 6 HIS A 67 -7.45 71.84 REMARK 500 7 ASN A 34 -77.31 -94.95 REMARK 500 7 LEU A 61 32.29 -98.10 REMARK 500 8 LEU A 61 35.19 -94.25 REMARK 500 9 SER A 3 18.63 54.86 REMARK 500 9 ASN A 65 -57.96 -139.62 REMARK 500 10 LEU A 29 -51.87 -135.81 REMARK 500 10 ASP A 32 -63.36 -135.73 REMARK 500 11 ASN A 34 -79.44 -81.03 REMARK 500 11 ASP A 62 77.79 55.97 REMARK 500 12 LEU A 29 -160.67 -124.83 REMARK 500 12 ASP A 62 73.07 53.75 REMARK 500 13 ASP A 62 70.16 57.05 REMARK 500 14 LEU A 61 35.89 -98.93 REMARK 500 15 MET A 4 71.18 -103.79 REMARK 500 15 GLU A 21 35.33 -96.54 REMARK 500 15 VAL A 30 89.92 61.72 REMARK 500 15 ASP A 62 75.35 50.55 REMARK 500 17 ASN A 65 78.55 55.54 REMARK 500 17 ILE A 69 38.22 -81.05 REMARK 500 18 VAL A 30 91.17 -63.36 REMARK 500 18 LEU A 64 -163.56 -100.94 REMARK 500 19 SER A 3 -90.55 49.11 REMARK 500 19 MET A 4 -14.00 70.66 REMARK 500 19 ASP A 32 -18.31 69.99 REMARK 500 19 ASP A 62 -56.32 73.28 REMARK 500 19 ALA A 68 -30.48 70.05 REMARK 500 19 ILE A 69 23.54 -72.94 REMARK 500 20 VAL A 30 114.29 -167.73 REMARK 500 20 ASP A 62 74.64 55.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EHCHA.10365.A RELATED DB: TARGETDB DBREF 2KZ0 A 4 76 UNP Q2GHF9 Q2GHF9_EHRCR 1 73 SEQADV 2KZ0 PRO A 1 UNP Q2GHF9 EXPRESSION TAG SEQADV 2KZ0 GLY A 2 UNP Q2GHF9 EXPRESSION TAG SEQADV 2KZ0 SER A 3 UNP Q2GHF9 EXPRESSION TAG SEQRES 1 A 76 PRO GLY SER MET THR VAL THR GLN SER GLN LEU GLU LEU SEQRES 2 A 76 LEU ILE ARG ASN ALA PHE PRO GLU ALA GLU ILE THR VAL SEQRES 3 A 76 THR SER LEU VAL GLY ASP ASN ASN HIS TYR SER ILE LYS SEQRES 4 A 76 VAL ILE SER SER GLN PHE GLN GLY LYS SER LYS LEU GLU SEQRES 5 A 76 GLN HIS ARG MET ILE TYR LYS VAL LEU ASP GLY LEU ASN SEQRES 6 A 76 ILE HIS ALA ILE GLN ILE GLN THR GLY CYS LYS HELIX 1 1 GLN A 8 PHE A 19 1 12 HELIX 2 2 GLN A 44 GLN A 46 5 3 HELIX 3 3 SER A 49 LEU A 61 1 13 SHEET 1 A 3 ALA A 22 THR A 27 0 SHEET 2 A 3 SER A 37 SER A 42 -1 O LYS A 39 N THR A 25 SHEET 3 A 3 ILE A 71 THR A 73 1 O GLN A 72 N ILE A 38 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1